Become A Featured Company

DionyMed Brands Expands Its Cannabis Brands Portfolio

Ryan Allway

March 13th, 2019

News

DionyMed Brands Inc. (“DionyMed” or “Company”) (CSE: DYME), a multi-state cannabis brands, distribution and delivery platform, announced today the expansion of its wholly-owned, award-winning brand, Winberry Farms, to offer consumers an even more comprehensive, diversified product portfolio with 12 new CBD-focused products. With these new additions, the Winberry Farms product line will encompass 75 high-quality distillate and full-spectrum THC and CBD concentrates, currently available in 300 retail locations in Oregon and 50 locations in California. One of the first recreational cannabis farms to be licensed by the state of Oregon, Winberry Farms specializes in expertly-cultivated, naturally sun-grown product.

The launch of the new Winberry Farms CBD line in California includes 16 skus, which will be available in multiple flavors and configurations, offering both 3:1 and 1:1 CBD to THC ratios.

Edward Fields, CEO of DionyMed, said, “Through Winberry Farms and our other emerging brands, we are committed to providing the safest, highest-quality products and solutions to all medical and recreational consumers in the states in which DionyMed operates. As CBD continues to gain traction across the country as a new and important component of a day-to-day health and wellness regimen, our products ensure that our customers have access to highest quality products and a variety of options to meet their diverse needs.”

DionyMed’s Wholly-Owned Brands

In addition to Winberry Farms, the Company’s wholly-owned brand portfolio includes the following:

  • Gardeners – Quality cannabis flower from local growers offered at a high-value price point. Over 24 unique products, including pre-rolls, available across California.
  • Afterglow – A limited edition product line of flower and live resin sauce featuring popular, limited run strains from a top grower, available across California.

DionyMed’s Portfolio Brands

In addition to DionyMed’s wholly-owned brands, the Company has established relationships with premier cannabis brands to offer its direct-to-consumer and retail distribution capabilities and further enhance and build upon the Company’s position as a “house of brands.” These brands currently include:

  • Herbology – A collection of ultra-pure extracts for the new G Pen Gio vaporizer. Established in 2011, Herbology is a pioneer in testing and analyzing cannabinoids. This is a Northern California exclusive distribution partner.
  • Headwaters – With a mission of supplying reliable, compliant, and conscious cannabis, Headwaters flower is guided by tenets of sustainable agriculture and driven by a commitment to transparency. This is a California state-wide distribution partnership.
  • Lifestyle Delivery Systems (LDS) – LDS markets the brand Reveur, a top-tier live resin at an affordable price, and CannaStrips(TM). CannaStrips offer an effective dosage with no degradation of the liver. The result is a consistent, precise, and effective experience. This is an exclusive California statewide distribution partnership.
  • HigherVeda Medicinals – Inspired by the ancient healing principles of Ayurveda, HigherVeda Medicinals are wholesome effect-based capsules for consumers who prioritize balance and quality. This is a California state-wide distribution partnership.
  • Fire King – Fire King is a premium icewater hash. This is a California state-wide distributor partnership.

To be added to the DionyMed e-mail distribution list, please e-mail DionyMed@kcsa.com with DionyMed in the subject line.

About DionyMed

Founded in 2017, DionyMed is a multi-state cannabis brands, distribution and delivery platform, supporting cultivators, manufacturers and award-winning brands in the medical and adult-use cannabis markets. DionyMed sells branded products in every category from flower to vape cartridges, concentrates and edibles. DionyMed serves more than 700 dispensaries and completes over 40,000 Direct-To-Consumer deliveries each month with its growing portfolio of products and brands. Learn more at www.DionyMed.com and follow @DYME_Inc on Twitter and LinkedIn.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading